Postirradiation changes of plasma coagulation factors and inhibitors of coagulation. 1987

P Klír, and D Hlousková, and J Pospísil, and F Kase

UI MeSH Term Description Entries
D011516 Prothrombin A plasma protein that is the inactive precursor of thrombin. It is converted to thrombin by a prothrombin activator complex consisting of factor Xa, factor V, phospholipid, and calcium ions. Deficiency of prothrombin leads to hypoprothrombinemia. Coagulation Factor II,Factor II,Blood Coagulation Factor II,Differentiation Reversal Factor,Factor II, Coagulation,Factor, Differentiation Reversal,II, Coagulation Factor
D011832 Radiation Injuries Harmful effects of non-experimental exposure to ionizing or non-ionizing radiation in VERTEBRATES. Radiation Sickness,Radiation Syndrome,Injuries, Radiation,Injury, Radiation,Radiation Injury,Radiation Sicknesses,Radiation Syndromes,Sickness, Radiation,Sicknesses, Radiation,Syndrome, Radiation,Syndromes, Radiation
D001779 Blood Coagulation Factors Endogenous substances, usually proteins, that are involved in the blood coagulation process. Clotting Factor,Coagulation Factors,Blood Coagulation Factor,Clotting Factors,Coagulation Factor,Coagulation Factor, Blood,Coagulation Factors, Blood,Factor, Coagulation,Factors, Coagulation,Factor, Blood Coagulation,Factor, Clotting,Factors, Blood Coagulation,Factors, Clotting
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D006470 Hemorrhage Bleeding or escape of blood from a vessel. Bleeding,Hemorrhages
D006494 Heparin Antagonists Coagulant substances inhibiting the anticoagulant action of heparin. Antagonists, Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000990 Antithrombin III A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily. Heparin Cofactor I,Antithrombin III-Alpha,Atenativ,Heparin Co-Factor I,Kybernin,Serpin C1,Thrombate III,Antithrombin III Alpha,Antithrombin IIIAlpha,Cofactor I, Heparin,Heparin Co Factor I
D013577 Syndrome A characteristic symptom complex. Symptom Cluster,Cluster, Symptom,Clusters, Symptom,Symptom Clusters,Syndromes

Related Publications

P Klír, and D Hlousková, and J Pospísil, and F Kase
March 2004, Vnitrni lekarstvi,
P Klír, and D Hlousková, and J Pospísil, and F Kase
December 1994, Current opinion in structural biology,
P Klír, and D Hlousková, and J Pospísil, and F Kase
September 1975, Thrombosis et diathesis haemorrhagica,
P Klír, and D Hlousková, and J Pospísil, and F Kase
May 1954, La Presse medicale,
P Klír, and D Hlousková, and J Pospísil, and F Kase
January 1994, Rinsho byori. The Japanese journal of clinical pathology,
P Klír, and D Hlousková, and J Pospísil, and F Kase
October 2000, Clinical and laboratory haematology,
P Klír, and D Hlousková, and J Pospísil, and F Kase
January 1986, Vutreshni bolesti,
P Klír, and D Hlousková, and J Pospísil, and F Kase
January 1985, Journal of clinical apheresis,
P Klír, and D Hlousková, and J Pospísil, and F Kase
January 1982, Transfusion,
P Klír, and D Hlousková, and J Pospísil, and F Kase
January 1978, Archivio per le scienze mediche,
Copied contents to your clipboard!